BNTX logo

BioNTech SE (BNTX) Selling, General & Administrative Expenses

Annual SG&A:

$647.93M+$44.99M(+7.46%)
December 31, 2024

Summary

  • As of today, BNTX annual SG&A is $647.93 million, with the most recent change of +$44.99 million (+7.46%) on December 31, 2024.
  • During the last 3 years, BNTX annual SG&A has risen by +$250.55 million (+63.05%).
  • BNTX annual SG&A is now at all-time high.

Performance

BNTX SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly SG&A:

$0.00-$155.86M(-100.00%)
September 30, 2025

Summary

  • As of today, BNTX quarterly SG&A is $0.00, with the most recent change of -$155.86 million (-100.00%) on September 30, 2025.
  • Over the past year, BNTX quarterly SG&A has dropped by -$165.33 million (-100.00%).
  • BNTX quarterly SG&A is now -100.00% below its all-time high of $197.87 million, reached on June 30, 2024.

Performance

BNTX Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM SG&A:

$82.90B+$438.90M(+0.53%)
September 30, 2025

Summary

  • As of today, BNTX TTM SG&A is $82.90 billion, with the most recent change of +$438.90 million (+0.53%) on September 30, 2025.
  • Over the past year, BNTX TTM SG&A has increased by +$82.25 billion (+12791.14%).
  • BNTX TTM SG&A is now -1.51% below its all-time high of $84.16 billion.

Performance

BNTX TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

BNTX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+7.5%-100.0%+10000.0%
3Y3 Years+63.0%-100.0%+10000.0%
5Y5 Years+1099.4%-100.0%+10000.0%

BNTX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+63.0%-100.0%at low-1.5%+42.9%
5Y5-Yearat high+1099.4%-100.0%at low-1.5%+3322.0%
All-TimeAll-Timeat high+1807.0%-100.0%at low-1.5%+3322.0%

BNTX Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(-100.0%)
$423.69M(-28.1%)
Jun 2025
-
$155.86M(+22.8%)
$589.02M(-6.7%)
Mar 2025
-
$126.93M(-9.9%)
$631.04M(-2.6%)
Dec 2024
$647.93M(+7.5%)
$140.91M(-14.8%)
$648.03M(+0.8%)
Sep 2024
-
$165.33M(-16.4%)
$643.05M(-1.2%)
Jun 2024
-
$197.87M(+37.5%)
$650.58M(+7.4%)
Mar 2024
-
$143.92M(+5.9%)
$605.95M(+0.5%)
Dec 2023
$602.94M(+5.4%)
$135.93M(-21.4%)
$603.23M(-0.7%)
Sep 2023
-
$172.86M(+12.8%)
$607.55M(+3.1%)
Jun 2023
-
$153.24M(+8.5%)
$589.53M(-0.7%)
Mar 2023
-
$141.20M(+0.7%)
$593.59M(+4.1%)
Dec 2022
$571.94M(+43.9%)
$140.26M(-9.4%)
$570.29M(-5.0%)
Sep 2022
-
$154.83M(-1.6%)
$600.12M(+11.5%)
Jun 2022
-
$157.30M(+33.4%)
$538.05M(+18.4%)
Mar 2022
-
$117.90M(-30.7%)
$454.41M(+15.4%)
DateAnnualQuarterlyTTM
Dec 2021
$397.38M(+221.1%)
$170.08M(+83.3%)
$393.84M(+43.3%)
Sep 2021
-
$92.77M(+25.9%)
$274.79M(+28.2%)
Jun 2021
-
$73.66M(+28.5%)
$214.27M(+30.1%)
Mar 2021
-
$57.33M(+12.4%)
$164.69M(+31.4%)
Dec 2020
$123.76M(+129.1%)
$51.03M(+58.2%)
$125.32M(+52.9%)
Sep 2020
-
$32.25M(+33.9%)
$81.94M(+31.7%)
Jun 2020
-
$24.08M(+34.1%)
$62.20M(+16.1%)
Mar 2020
-
$17.96M(+134.7%)
$53.56M(+17.3%)
Dec 2019
$54.02M(+55.9%)
$7.65M(-38.8%)
$45.67M(-5.1%)
Sep 2019
-
$12.51M(-19.0%)
$48.13M(+9.0%)
Jun 2019
-
$15.44M(+53.3%)
$44.14M(+53.8%)
Mar 2019
-
$10.07M(-0.4%)
$28.70M(+54.1%)
Dec 2018
$34.66M(+2.0%)
$10.11M(+18.6%)
$18.63M(+118.6%)
Sep 2018
-
$8.52M
$8.52M
Dec 2017
$33.98M
-
-

FAQ

  • What is BioNTech SE annual SG&A?
  • What is the all-time high annual SG&A for BioNTech SE?
  • What is BioNTech SE annual SG&A year-on-year change?
  • What is BioNTech SE quarterly SG&A?
  • What is the all-time high quarterly SG&A for BioNTech SE?
  • What is BioNTech SE quarterly SG&A year-on-year change?
  • What is BioNTech SE TTM SG&A?
  • What is the all-time high TTM SG&A for BioNTech SE?
  • What is BioNTech SE TTM SG&A year-on-year change?

What is BioNTech SE annual SG&A?

The current annual SG&A of BNTX is $647.93M

What is the all-time high annual SG&A for BioNTech SE?

BioNTech SE all-time high annual SG&A is $647.93M

What is BioNTech SE annual SG&A year-on-year change?

Over the past year, BNTX annual SG&A has changed by +$44.99M (+7.46%)

What is BioNTech SE quarterly SG&A?

The current quarterly SG&A of BNTX is $0.00

What is the all-time high quarterly SG&A for BioNTech SE?

BioNTech SE all-time high quarterly SG&A is $197.87M

What is BioNTech SE quarterly SG&A year-on-year change?

Over the past year, BNTX quarterly SG&A has changed by -$165.33M (-100.00%)

What is BioNTech SE TTM SG&A?

The current TTM SG&A of BNTX is $82.90B

What is the all-time high TTM SG&A for BioNTech SE?

BioNTech SE all-time high TTM SG&A is $84.16B

What is BioNTech SE TTM SG&A year-on-year change?

Over the past year, BNTX TTM SG&A has changed by +$82.25B (+12791.14%)
On this page